New study to test which COVID-19 vaccine works best for At-Risk adults
NCT ID NCT07287137
First seen Jan 11, 2026 · Last updated May 02, 2026 · Updated 20 times
Summary
This study compares how well two FDA-approved COVID-19 vaccines (Novavax and Pfizer-BioNTech) and flu vaccines work in adults aged 18-79 who have health risks like asthma, heart disease, or depression. Researchers will measure immune responses and side effects over time. The goal is to understand which vaccines provide the best protection against current virus variants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID - 19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Walter Reed National Military Medical Center
RECRUITINGBethesda, Maryland, 20814, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.